Loading clinical trials...
Loading clinical trials...
Improving the Diagnosis of Common Variable Immune Deficiency by Analysis of Innate and Adaptive Signaling Pathways
Conditions
Locations
1
United States
UCLA
Los Angeles, California, United States
Start Date
May 1, 2019
Primary Completion Date
December 31, 2021
Completion Date
June 1, 2022
Last Updated
April 20, 2026
Lead Sponsor
University of California, Los Angeles
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions